View Older Stories View More Recent Stories

Nov 8, 2019 07:14AM Rubius Therapeutics (RUBY) Announces Preclinical Data Supporting Lead Artificial Antigen Presenting Cell Program, RTX-321
Nov 8, 2019 07:00AM Rubius Therapeutics Highlights Preclinical Oncology Data at Society for Immunotherapy of Cancer Annual Meeting and AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Nov 8, 2019 07:00AM Rubius Therapeutics Highlights Preclinical Oncology Data at Society for Immunotherapy of Cancer Annual Meeting and AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Nov 5, 2019 04:05PM Rubius Therapeutics to Announce Third Quarter 2019 Financial Results
Nov 5, 2019 04:05PM Rubius Therapeutics to Announce Third Quarter 2019 Financial Results
Oct 17, 2019 08:00AM Rubius Therapeutics Announces Oncology Poster Presentations at Upcoming Medical Conferences
Oct 17, 2019 08:00AM Rubius Therapeutics Announces Oncology Poster Presentations at Upcoming Medical Conferences
Sep 3, 2019 04:05PM Rubius Therapeutics to Participate in 17th Annual Morgan Stanley Global Healthcare Conference
Sep 3, 2019 04:05PM Rubius Therapeutics to Participate in 17th Annual Morgan Stanley Global Healthcare Conference
Aug 13, 2019 08:00AM Rubius Therapeutics Reports Second Quarter 2019 Financial Results and Operational Progress
Aug 13, 2019 08:00AM Rubius Therapeutics Reports Second Quarter 2019 Financial Results and Operational Progress
Aug 7, 2019 04:05PM Rubius Therapeutics to Announce Second Quarter 2019 Financial Results
Aug 7, 2019 04:05PM Rubius Therapeutics to Announce Second Quarter 2019 Financial Results
Jul 25, 2019 08:00AM Rubius Therapeutics Appoints Kris Elverum as Senior Vice President of Business Development and Strategy
Jul 25, 2019 08:00AM Rubius Therapeutics Appoints Kris Elverum as Senior Vice President of Business Development and Strategy
Jun 5, 2019 08:06AM Rubius Therapeutics (RUBY) Announces Issuance of Multiple U.S. Patents for its Red Cell Therapeutic Programs
Jun 5, 2019 08:00AM Rubius Therapeutics Announces Issuance of Multiple U.S. Patents for its Red Cell Therapeutic Programs
Jun 5, 2019 08:00AM Rubius Therapeutics Announces Issuance of Multiple U.S. Patents for its Red Cell Therapeutic Programs
May 28, 2019 04:05PM Rubius Therapeutics to Present at Jefferies 2019 Healthcare Conference
May 28, 2019 04:05PM Rubius Therapeutics to Present at Jefferies 2019 Healthcare Conference
May 15, 2019 08:00AM Rubius Therapeutics Reports First Quarter 2019 Financial Results and Operational Progress
May 15, 2019 08:00AM Rubius Therapeutics Reports First Quarter 2019 Financial Results and Operational Progress
May 6, 2019 04:05PM Rubius Therapeutics to Announce First Quarter 2019 Financial Results
May 6, 2019 04:05PM Rubius Therapeutics to Announce First Quarter 2019 Financial Results
Apr 3, 2019 04:05PM Rubius Therapeutics to Participate in Jefferies 6th Annual IO Cell Therapy Summit
Apr 3, 2019 04:05PM Rubius Therapeutics to Participate in Jefferies 6th Annual IO Cell Therapy Summit
Apr 2, 2019 08:00AM Rubius Therapeutics Announces Extensive Preclinical Data for Three Red Cell Therapeutic Oncology Programs at the 2019 American Association for Cancer Research Annual Meeting
Apr 2, 2019 08:00AM Rubius Therapeutics Announces Extensive Preclinical Data for Three Red Cell Therapeutic Oncology Programs at the 2019 American Association for Cancer Research Annual Meeting
Mar 28, 2019 08:00AM Rubius Therapeutics Reports Fourth Quarter and Full-Year 2018 Financial Results with Business Updates
Mar 28, 2019 08:00AM Rubius Therapeutics Reports Fourth Quarter and Full-Year 2018 Financial Results with Business Updates
Mar 25, 2019 08:05AM Rubius Therapeutics (RUBY) Announces Natalie Holles to Board
Mar 25, 2019 08:00AM Rubius Therapeutics Appoints Natalie Holles to its Board of Directors and Greg Whitehead as Senior Vice President and Chief Quality Officer
Mar 25, 2019 08:00AM Rubius Therapeutics Appoints Natalie Holles to its Board of Directors and Greg Whitehead as Senior Vice President and Chief Quality Officer
Mar 19, 2019 04:05PM Rubius Therapeutics to Announce Fourth Quarter and Full-Year 2018 Financial Results
Mar 19, 2019 04:05PM Rubius Therapeutics to Announce Fourth Quarter and Full-Year 2018 Financial Results
Mar 11, 2019 08:07AM Rubius Therapeutics (RUBY) Reports FDA Clearance of Investigational NDA for RTX-134 for Treatment of Phenylketonuria
Mar 11, 2019 08:00AM Rubius Therapeutics Announces FDA Clearance of Investigational New Drug Application for First-Ever Red Cell Therapeutic, RTX-134, for Treatment of Phenylketonuria
Mar 11, 2019 04:00AM Rubius Therapeutics Announces FDA Clearance of Investigational New Drug Application for First-Ever Red Cell Therapeutic, RTX-134, for Treatment of Phenylketonuria
Feb 27, 2019 04:35PM Rubius Therapeutics Announces Poster Presentations at the 2019 American Association for Cancer Research Annual Meeting
Feb 27, 2019 04:35PM Rubius Therapeutics Announces Poster Presentations at the 2019 American Association for Cancer Research Annual Meeting
Feb 19, 2019 04:05PM Rubius Therapeutics to Participate at Upcoming Investor Conferences
Feb 19, 2019 04:05PM Rubius Therapeutics to Participate at Upcoming Investor Conferences
Jan 7, 2019 08:06AM Rubius Therapeutics (RUBY) Highlights Upcoming 2019 Milestones at J.P. Morgan Healthcare Conference
Jan 7, 2019 08:00AM Rubius Therapeutics Highlights Upcoming 2019 Milestones at the 37th Annual J.P. Morgan Healthcare Conference
Jan 7, 2019 08:00AM Rubius Therapeutics Highlights Upcoming 2019 Milestones at the 37th Annual J.P. Morgan Healthcare Conference
Dec 27, 2018 04:05PM Rubius Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference
Dec 27, 2018 04:05PM Rubius Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference
Dec 21, 2018 12:15PM Rubius Therapeutics, Inc. Secures $75 Million Loan Facility
Dec 21, 2018 12:15PM Rubius Therapeutics, Inc. Secures $75 Million Loan Facility
Dec 17, 2018 04:05PM Rubius Therapeutics Added to Nasdaq Biotechnology Index
View More Recent Stories View Older Stories